TY - JOUR
T1 - Multiple Myeloma, version 3.2018
T2 - Featured updates to the NCCN guidelines
AU - Kumar, Shaji K.
AU - Callander, Natalie S.
AU - Alsina, Melissa
AU - Atanackovic, Djordje
AU - Biermann, J. Sybil
AU - Castillo, Jorge
AU - Chandler, Jason C.
AU - Costello, Caitlin
AU - Faiman, Matthew
AU - Fung, Henry C.
AU - Godby, Kelly
AU - Hofmeister, Craig
AU - Holmberg, Leona
AU - Holstein, Sarah
AU - Huff, Carol Ann
AU - Kang, Yubin
AU - Kassim, Adetola
AU - Liedtke, Michaela
AU - Malek, Ehsan
AU - Martin, Thomas
AU - Neppalli, Vishala T.
AU - Omel, James
AU - Raje, Noopur
AU - Singhal, Seema
AU - Somlo, George
AU - Stockerl-Goldstein, Keith
AU - Weber, Donna
AU - Yahalom, Joachim
AU - Kumar, Rashmi
AU - Shead, Dorothy A.
N1 - Funding Information:
This activity is supported by educational grants from AstraZeneca, Celldex Therapeutics, Celgene Corporation, Genentech, Jazz Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, and Seattle Genetics, Inc. This activity is supported by independent educational grants from AbbVie, Merck & Co., Inc. and NOVOCURE.
Publisher Copyright:
© 2018 JNCCN-Journal of the National Comprehensive Cancer Network.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive-care, and follow-up for patients with myeloma. These NCCN Guidelines Insights highlight the important updates/changes specific to the myeloma therapy options in the 2018 version of the NCCN Guidelines.
AB - The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive-care, and follow-up for patients with myeloma. These NCCN Guidelines Insights highlight the important updates/changes specific to the myeloma therapy options in the 2018 version of the NCCN Guidelines.
UR - http://www.scopus.com/inward/record.url?scp=85040224540&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2018.0002
DO - 10.6004/jnccn.2018.0002
M3 - Review article
C2 - 29295877
AN - SCOPUS:85040224540
SN - 1540-1405
VL - 16
SP - 11
EP - 20
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 1
ER -